Watch this segment to gain expert insights in metastatic CSPC, and then visit https://i3health.com/course-information/cspc-escape to explore the full escape room experience.
In this video, Dr. Ulka Vaishampayan, Professor of Medicine/Oncology and Co-Leader of the Translational Clinical Research Program at the University of Michigan Rogel Cancer Center @MichiganMedicine provides details on the factors involved in the treatment of patients with metastatic castration-sensitive prostate cancer (CSPC), including:
- Disease-related factors
- Impact of prior therapy
- Patient-related factors and patient preferences
Follow us here:
Facebook https://www.facebook.com/i3Health
Instagram https://www.instagram.com/i3health
Linkedin https://www.linkedin.com/company/i3health
Soundcloud https://soundcloud.com/i3-health
X https://twitter.com/i3health
#prostatecancer #CSPC #Oncology #MetastaticProstateCancer #MedicalEducation #News #education #cme #cancer #cancertreatment #earlydiagnosis #patientcare #cancercare #cancerpatient #cancerdetection #prostatecancerawareness #urology #prostatehealth
In this video, Dr. Ulka Vaishampayan, Professor of Medicine/Oncology and Co-Leader of the Translational Clinical Research Program at the University of Michigan Rogel Cancer Center @MichiganMedicine provides details on the factors involved in the treatment of patients with metastatic castration-sensitive prostate cancer (CSPC), including:
- Disease-related factors
- Impact of prior therapy
- Patient-related factors and patient preferences
Follow us here:
Facebook https://www.facebook.com/i3Health
Instagram https://www.instagram.com/i3health
Linkedin https://www.linkedin.com/company/i3health
Soundcloud https://soundcloud.com/i3-health
X https://twitter.com/i3health
#prostatecancer #CSPC #Oncology #MetastaticProstateCancer #MedicalEducation #News #education #cme #cancer #cancertreatment #earlydiagnosis #patientcare #cancercare #cancerpatient #cancerdetection #prostatecancerawareness #urology #prostatehealth
- Categoria
- Oncology
Commenta per primo questo video.









